DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

CORONA Remedies Limited — Board Meeting Intimation

NSE 53 min ago·16 Oct 2026, 6:54 am

CORONA Remedies

Corona Remedies Limited has announced a board meeting scheduled for October 30, 2026. The primary agenda for this session is to review and approve the company's unaudited financial results for the quarter ending September 2026. This is a standard corporate procedure where the board evaluates the firm's performance before the figures are formally released to the public and regulatory exchanges.

This announcement is a routine update for investors, but it marks a key milestone in the company's reporting cycle. The upcoming results will provide the first glimpse into the company's financial health and operational progress during the third quarter of the fiscal year. Market participants will closely watch the data to gauge the company's trajectory and strategy execution.

Investors should wait for the official release of the financial statements to assess the company's performance. The market will likely react to the details of the results, including revenue growth and profitability metrics. Keeping an eye on the official filing will be essential for understanding the company's current standing and future outlook.